Robert E. Landry

Regeneron Pharmaceuticals

Senior Vice President, Finance and Chief Financial Officer

Overview

Robert E. Landry made an average of $7.9M in compensation at Regeneron Pharmaceuticals from 2013 to 2018.

Annual data

2018

In 2018, Robert E. Landry earned a total compensation of $9.4M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking639 out of 10,821
Percentile94.1%

Robert E. Landry's 2018 compensation ranked 639th out of 10,821 executive pay records tracked by us this year.

Landry earned more than 94.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking47 out of 1,216
Percentile96.1%

In the industry group of Drugs, Landry's pay ranked 47th out of 1,216 executive pay records tracked by us in 2018.

Landry earned more than 96.1% of executives in this group.

Non-Equity Incentive Plan$581,400
Option Awards$3,308,184
Salary$680,000
Stock Awards$4,767,500
Other$19,535
Total$9,356,619

Landry received $4.8M in stock awards, which accounts for 50.95% of total compensation.

Landry also received $581.4K in non-equity incentive plan, $3.3M in option awards, $680K in salary and $19.5K in other compensation.

2017

In 2017, Robert E. Landry earned a total compensation of $4.8M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking1,889 out of 13,725
Percentile86.2%

Robert E. Landry's 2017 compensation ranked 1,889th out of 13,725 executive pay records tracked by us this year.

Landry earned more than 86.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking126 out of 1,553
Percentile91.9%

In the industry group of Drugs, Landry's pay ranked 126th out of 1,553 executive pay records tracked by us in 2017.

Landry earned more than 91.9% of executives in this group.

Non-Equity Incentive Plan$482,040
Option Awards$3,675,566
Salary$618,000
Other$19,130
Total$4,794,736

Landry received $3.7M in option awards, which accounts for 76.66% of total compensation.

Landry also received $482K in non-equity incentive plan, $618K in salary and $19.1K in other compensation.

2016

In 2016, Robert E. Landry earned a total compensation of $5.2M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking1,532 out of 14,026
Percentile89.1%

Robert E. Landry's 2016 compensation ranked 1,532nd out of 14,026 executive pay records tracked by us this year.

Landry earned more than 89.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking98 out of 1,495
Percentile93.4%

In the industry group of Drugs, Landry's pay ranked 98th out of 1,495 executive pay records tracked by us in 2016.

Landry earned more than 93.4% of executives in this group.

Non-Equity Incentive Plan$439,200
Option Awards$4,121,229
Salary$585,600
Other$18,700
Total$5,164,729

Landry received $4.1M in option awards, which accounts for 79.80% of total compensation.

Landry also received $439.2K in non-equity incentive plan, $585.6K in salary and $18.7K in other compensation.

2015

In 2015, Robert E. Landry earned a total compensation of $8.2M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking746 out of 13,577
Percentile94.5%

Robert E. Landry's 2015 compensation ranked 746th out of 13,577 executive pay records tracked by us this year.

Landry earned more than 94.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking70 out of 1,485
Percentile95.3%

In the industry group of Drugs, Landry's pay ranked 70th out of 1,485 executive pay records tracked by us in 2015.

Landry earned more than 95.3% of executives in this group.

Bonus$465,750
Option Awards$7,246,284
Salary$517,500
Other$19,360
Total$8,248,894

Landry received $7.2M in option awards, which accounts for 87.85% of total compensation.

Landry also received $465.8K in bonus, $517.5K in salary and $19.4K in other compensation.

2014

In 2014, Robert E. Landry earned a total compensation of $7.4M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking883 out of 12,912
Percentile93.2%

Robert E. Landry's 2014 compensation ranked 883rd out of 12,912 executive pay records tracked by us this year.

Landry earned more than 93.2% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking78 out of 1,315
Percentile94.1%

In the industry group of Drugs, Landry's pay ranked 78th out of 1,315 executive pay records tracked by us in 2014.

Landry earned more than 94.1% of executives in this group.

Bonus$455,000
Option Awards$6,403,138
Salary$500,000
Other$14,818
Total$7,372,956

Landry received $6.4M in option awards, which accounts for 86.85% of total compensation.

Landry also received $455K in bonus, $500K in salary and $14.8K in other compensation.

2013

In 2013, Robert E. Landry earned a total compensation of $12.6M as Senior Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals.

Ranking247 out of 12,019
Percentile97.9%

Robert E. Landry's 2013 compensation ranked 247th out of 12,019 executive pay records tracked by us this year.

Landry earned more than 97.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking14 out of 1,097
Percentile98.7%

In the industry group of Drugs, Landry's pay ranked 14th out of 1,097 executive pay records tracked by us in 2013.

Landry earned more than 98.7% of executives in this group.

Bonus$50,000
Option Awards$11,054,274
Salary$144,231
Stock Awards$1,363,500
Other$1,130
Total$12,613,135

Landry received $11.1M in option awards, which accounts for 87.64% of total compensation.

Landry also received $50K in bonus, $144.2K in salary, $1.4M in stock awards and $1.1K in other compensation.